1034616-18-6
1034616-18-6
Chemical Structure
Onvansertib
Synonym(s): NMS-1286937; NMS-P937
- CAS No.: 1034616-18-6
- Formula:C24H27F3N8O3
- Molecular Weight:532.52
IUPAC Name: 1-(2-hydroxyethyl)-8-((5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
InChIKey: QHLVBNKYJGBCQJ-UHFFFAOYSA-N
SMILES: O=C(C1=NN(CCO)C2=C1CCC3=CN=C(NC4=CC(N5CCN(C)CC5)=CC=C4OC(F)(F)F)N=C23)N
Biological Activity: NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM.
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Onvansertib | 99.86% | NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Onvansertib (Standard) | ≥98% | Onvansertib (Standard) is the analytical standard of Onvansertib (HY-15828). This product is intended for research and analytical applications. NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
